BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4263510)

  • 1. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test.
    Miggiano VC; Bernoco D; Lightbody J; Trinchieri G; Ceppellini R
    Transplant Proc; 1972 Jun; 4(2):231-7. PubMed ID: 5034149
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 4. The cellular immunity of mother versus child at delivery: sensitization in unidirectional mixed lymphocyte culture and subsequent 51-Cr-release cytotoxicity test.
    Bonnard GD; Lemos L
    Transplant Proc; 1972 Jun; 4(2):177-80. PubMed ID: 5034146
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro correlates of cell-mediated immunity in the human.
    Bach JF
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous plasma affecting the maternal response in mixed lymphocyte cultures with the newborn.
    Imre G; Petri I; Keserü TL; Obál M
    Haematologia (Budap); 1973; 7(2):193-8. PubMed ID: 4275101
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
    Sharma B; Koashi O; Mickey MR; Terasaki P
    Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte reactivity in vitro. VI. Specificity of target cell destruction following in vitro sensitization in mixed leukocyte cultures.
    Solliday S; Bach FH
    Eur J Immunol; 1972 Feb; 2(1):68-72. PubMed ID: 4263648
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 10. The response of alloimmune human lymphocytes in mixed lymphocyte culture tests.
    Bondevik H; Thorsby E
    Transplant Proc; 1973 Dec; 5(4):1477-80. PubMed ID: 4272813
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation of cytotoxic lymphocytes in mixed leukocyte culture systems: introduction.
    Cerottini JC; MacDonald HR; Brunner KT
    Transplant Proc; 1973 Dec; 5(4):1621-4. PubMed ID: 4130070
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc.
    Phillips SM; Strom TB; Corson JM; Carpenter CB; Merrill JP
    Transplant Proc; 1973 Mar; 5(1):577-80. PubMed ID: 4266670
    [No Abstract]   [Full Text] [Related]  

  • 13. 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.
    McCoy JL; Herberman RB; Rosenberg EB; Donnelly FC; Levine PH; Alford C
    Natl Cancer Inst Monogr; 1973 Jun; 37():59-67. PubMed ID: 4123455
    [No Abstract]   [Full Text] [Related]  

  • 14. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells.
    Hunninghake GW; Fauci AS
    J Immunol; 1977 Sep; 119(3):1122-8. PubMed ID: 70470
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro immunization to cultured human tumor cells.
    Sharma B; Terasaki PI
    Cancer Res; 1974 Jan; 34(1):115-8. PubMed ID: 4129196
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures.
    Lightbody J; Bernoco D; Miggiano VC; Ceppellini R
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):243-54. PubMed ID: 5155939
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell mediated lympholysis: effect of papain on effector and target cells.
    Lightbody JJ; Bach FH
    Ann Immunol (Paris); 1973 Aug; 124(3):311-9. PubMed ID: 4272624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.